Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Similares en SciELO
Compartir
Gaceta médica de México
versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813
Resumen
GALLARDO-RINCON, Dolores et al. Recommendations on the pharmacological treatment of epithelial ovarian cancer in Mexico. Gac. Méd. Méx [online]. 2021, vol.157, n.spe1, pp.1-11. Epub 16-Mayo-2022. ISSN 2696-1288. https://doi.org/10.24875/gmm.m21000569.
Ovarian cancer is the third most frequent gynaecological malignancy worldwide and in Mexico, with a high mortality rate, due to that in many cases its diagnosis is made in advanced stages. Prognosis is important for determining the subtype and the degree of evolution. During lasts years, the management of ovarian cancer has undergone an important evolution with the incorporation of new therapeutic options, which in turn represent an increase in the survival of these patients. We present recommendations for the management of ovarian cancer developed by an expert panel Mexican based on available evidence so far and the characteristics of health care in the country.
Palabras llave : Ovarian epithelial cancer; Treatment; Recommendations; Mexico.